Health Hazards of E-Cigarettes and Heated Tobacco Products: a Comprehensive Analysis of Hazardous Substances and Regulatory Gaps
Clinical Snapshot
PICO Framework
| P — Population | Electronic cigarettes (ECs) and heated tobacco products (HTPs) - ingredients and emissions data from EU Common Entry Gate and scientific literature |
| I — Intervention | Systematic identification and hazard classification of substances in EC and HTP ingredients and emissions |
| C — Comparator | Existing health hazard classification systems and regulatory frameworks |
| O — Outcomes | Classification of 1740 substances into three hazard categories, with 134 substances identified as Category 1 (highest health hazard potential) |
Bottom Line
This systematic review identifies significant safety concerns with e-cigarettes and heated tobacco products, cataloguing 1740 substances with 134 classified as high-hazard including known carcinogens, mutagens, and reproductive toxicants. Many of these prohibited substances are found despite existing regulatory bans, highlighting enforcement gaps. For Australian clinicians, this reinforces the importance of evidence-based counselling about vaping risks, particularly for patients considering these products for smoking cessation. The findings support current TGA restrictions and suggest need for enhanced product safety monitoring. While the study provides valuable hazard identification, it lacks quantitative risk assessment data needed for individualised clinical decision-making. Healthcare providers should continue following established smoking cessation guidelines prioritising proven therapies while remaining informed about emerging safety data for alternative nicotine products.
Key Findings
P Value: Not applicable - descriptive analysis
Effect Size: 134 out of 1740 substances (7.7%) classified as Category 1 highest hazard
Primary Outcome: Classification of hazardous substances in EC and HTP products
Nnt Or Sensitivity: 134 high-priority substances identified for regulatory action and further research
Confidence Interval: Not reported
Clinical Application
High - provides practical framework for substance prioritisation and regulatory decision-making Highly relevant for TGA regulation of vaping products, supports evidence-based approach to therapeutic goods scheduling and import controls under current prescription-only framework Healthcare providers counselling patients on tobacco harm reduction, public health professionals developing vaping policies
Abstract
INTRODUCTION: Ingredients and products of electronic cigarettes (ECs) and heated tobacco products (HTPs) formed during heating are aerosolized and inhaled. Hazard information on ingredients and emissions is often unavailable. Our objective was to identify and classify substances in the ingredients and emissions of ECs and HTPs based on scientific hazard classifications. METHODS: Ingredient data were collected from the European Union (EU) Common Entry Gate, a mandatory notification system for tobacco and related products. Substances in ECs and HTPs emissions were identified with a systematic literature review and classified into three categories based on existing health hazard classifications. Category 1 substances (i.e., highest potential health hazard) were regarded as high-priority substances for research and quantification. Categories 2 and 3 included potentially harmful substances and substances lacking sufficient toxicological data respectively. RESULTS: A total of 134 of the 1740 identified substances were classified in Category 1. Several substances possess Carcinogenic, Mutagenic, or Reprotoxic properties, prohibited as tobacco additives. Most substances lacked sufficient toxicity data and were classified in Category 3. CONCLUSION: Our classification can be used for monitoring and enforcement, ensuring proactive management of potential risks. Therefore, we recommend strengthening the enforcement of existing bans. Implications: This study identifies and classifies 1740 substances found in the ingredients and emissions of ECs and HTPs, including 134 hazardous chemicals, among which are carcinogens, mutagens, and reproduction toxicants. This indicates regulatory gaps and the need for stricter enforcement of existing bans. The findings provide a valuable tool for policymakers and public health professionals for monitoring and mitigating risks.
References
- 1.El Bouz, M., Neto, C., Mansuy, T., Becher, R., Valen, H., Mariussen, E., Blanco-Escauriaza, D. A., González-Marrón, A., Zervas, E., Havermans, A., Talhout, R., & Staal, Y. C. M. (2026). Health hazards of e-cigarettes and heated tobacco products: A comprehensive analysis of hazardous substances and regulatory gaps. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntaf246
Related Research
PloS one
Factors associated with resilience among parents of children with autism spectrum disorder: A systematic review
23 June 2026
Cancer
Alcohol consumers' receptivity to artificial intelligence-generated alcohol-cancer risk messages: An experimental study.
15 June 2026
Human vaccines & immunotherapeutics
Immunogenicity and safety of AS03-adjuvanted A/Astrakhan/3212/2020 (H5N8)-like influenza vaccine in adults: Phase 1/2, observer-blinded, randomized trial
14 June 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service